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The intramacrophage protozoan parasites of Leishmania genus have developed
sophisticated ways to subvert the innate immune response permitting their infection
and propagation within the macrophages of the mammalian host. Several Leishmania
virulence factors have been identified and found to be of importance for the development
of leishmaniasis. However, recent findings are now further reinforcing the critical role
played by the zinc-metalloprotease GP63 as a virulence factor that greatly influence host
cell signaling mechanisms and related functions. GP63 has been found to be involved
not only in the cleavage and degradation of various kinases and transcription factors, but
also to be the major molecule modulating host negative regulatory mechanisms involving
for instance protein tyrosine phosphatases (PTPs). Those latter being well recognized for
their pivotal role in the regulation of a great number of signaling pathways. In this review
article, we are providing a complete overview about the role of Leishmania GP63 in the
mechanisms underlying the subversion of macrophage signaling and functions.
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INTRODUCTION
Parasites have always showed the greatest ingenuity when it is
time to infect their host, to survive and propagate, and the par-
asite Leishmania is clearly champion in this matter. Actually, it is
known that Leishmania can utilize various surface proteins, rec-
ognized as potential virulence factors [e.g., glycosilinositolphos-
pholipids (GIPLs), lipophosphoglycan (LPG), cysteine protease,
GP63], to thwart the host macrophage defense system and there-
fore, permitting its survival and progression within the harsh
environment of the phagolysosome (Chang andMcGwire, 2002).
Interestingly, one of them, the metalloprotease GP63, is more and
more seen as a critical one (Chaudhuri et al., 1989; Joshi et al.,
2002; Yao et al., 2003).
GP63 was first discovered in 1980s, being described as a major
surface antigen expressed on Leishmania promastigotes from var-
ious species (Fong and Chang, 1982; Bouvier et al., 1985; Etges
et al., 1985; Chang et al., 1986). Due to its glycosylation state, this
Leishmania surface protein (60–66 kDa), also showing capacity to
bind to concanavalin A, was named GP63 (Bouvier et al., 1985;
Chang et al., 1986; McGwire and Chang, 1996). Initially, GP63
was described to have protease activity, so named major surface
protease (MSP), and later on, specified as a zinc-metalloprotease
(Etges et al., 1986; Chaudhuri and Chang, 1988; Bouvier et al.,
1989; Chaudhuri et al., 1989). Because of this property, GP63 was
then name leishmanolysin by the IUBMB (International Union
of Biochemistry and Molecular Biology) Enzyme Nomenclature.
This metalloprotease is present not only in different species of
Leishmania, but also in various Trypanosoma species (sps) and
Trichomonas vaginalis (Etges et al., 1985; Bordier et al., 1986; Ma
et al., 2011a,b).
In the following sections of this review, we will report in details
what is GP63 and how this Leishmania virulence factor influences
the host innate immune system at cellular and molecular levels
concurring to its establishment, survival, and propagation within
mammalian macrophages.
GENOMIC ORGANIZATION, EXPRESSION, AND STRUCTURE
Genome sequence study of L. major showed that genes encod-
ing GP63 (msp) are organized in a tandem array (four copies)
on the chromosome 10, a single msp on the chromosome 28
and another related gene on the chromosome 31 (Ivens et al.,
2005). Similar organization of msp was found in L. infantum and
L. braziliensis genome which consist in 5 and 33 genes, respec-
tively, in the chromosome 10, as well as 3 and 6 msp-like in the
chromosome 28 and/or 31 (Peacock et al., 2007). Previous stud-
ies using Southern blots also demonstrated the tandem pattern
of msp, however, there are some contradiction in the numbers of
copies/parasite with the genome sequence results. Nevertheless,
those studies demonstrated that expression ofmsp products varies
with growth phase and life cycle form of Leishmania. Accordingly
with mRNA expression during growth phase, L. chagasi msp (>18
copies) were found to be organized in three classes mspL, S, and
C. mspS has 5 alleles mspS-1 to -5 and their products are mainly
expressed in stationary phase. On the other hand, products of
mspL-1 to -12 are expressed in the logarithmic phase. Finally,
a constitutively expressed mspC RNA seems to generate a GP63
transmembrane form (Roberts et al., 1993).
Differential expression of msp products is also demonstrated
during Leishmania life cycle. For instance, L. mexicana msp
genes (10 copies) were separated in clusters C1, C2, and C3.
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Products from all msp clusters are found in promastigotes, how-
ever, amastigotes only expresses GP63 from C1 msp cluster
(Medina-Acosta et al., 1989). Additionally, GP63 from L. major
msp genes 1–5 are expressed only in promastigotes, gene 6 in
both promastigote and amastigote, and gene 7 solely in amastig-
ote stage or in late promastigote stationary phase (Kelly et al.,
2001). These great numbers of GP63 genes generate abun-
dant proteins that can vary among species and life forms of
Leishmania leading to different biological effect, as we will discuss
later on.
GP63 protein synthesis is processed via endoplasmic reticu-
lum (ER) and secretory pathway by vesicles trafficking (Ellis et al.,
2002; McGwire et al., 2002; Yao et al., 2002). It can be found intra-
cellularly in ER (∼1.5%), but in great proportion expressed on
parasite surface (∼75%), and the rest is released under secreted
form or membrane cleaved (Weise et al., 2000; Ellis et al., 2002;
McGwire et al., 2002). Secreted GP63 can have different ranges of
molecular weight because of their glycosylated states important
for the secretion being independent of glycosylphosphatidyli-
nositol (GPI) anchor (Ellis et al., 2002) and whether they are
bearing a GPI anchor. Release of GPI-anchored GP63 is inde-
pendent on glycosylation, but dependent on auto-proteolysis, as
the presence of a zinc chelator, 1,10-phenanthroline or mutation
of zinc-binding motif did altered GPI-anchored GP63 secretion
(McGwire et al., 2002).
During the biosynthesis GP63 has a pro-peptide with a cys-
teine residue that inactivates the zinc protease activity. This pro-
peptide is removed during the protein maturation process. The
expression of GP63 on Leishmania surface and its secretion was
studied in many aspects relating with its role on the invertebrate
and vertebrate host of Leishmania. In the following section of this
review, we will now discuss GP63 impact on its host macrophage
functions.
IMPACT OF Leishmania GP63 ONMACROPHAGE
SIGNALING AND INNATE IMMUNE RESPONSE
See Figure 1 for schematic representation.
PROTEOLYTIC ACTIONS OF GP63
Upon their transmission to the host, Leishmania parasites are
in close contact with its innate immune system. However,
Leishmania evolved many mechanisms to escape from innate
inflammatory and microbicidal functions of macrophages,
and this by altering for instance several key signaling pathways
FIGURE 1 | Impact of Leishmania GP63 on macrophage signaling and
innate immune response. Before parasite entries into the host macrophage,
GP63 provides parasite resistance to the complement-mediated lysis and
facilitate promastigote engulfment by macrophages. Within the host
macrophage, GP63 is responsible for the activation of protein tyrosine
phosphatases (PTPs; SHP-1, PTP1B, and TCPTP) that lead to the alteration of
JAK, MAP, and IRAK-1 kinase pathways. GP63 is also able to down regulate
host macrophage protein synthesis by altering mTORC1-dependent signaling.
In the nucleus, inactivation of transcription factors, such as AP-1 and NF-κB,
involve specific cleavage and degradation of subunits by GP63. Altogether,
this signaling inactivation mediated by GP63 inhibits important antimicrobial,
thus favoring the survival and propagation of the parasite.
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(Olivier et al., 2005). How GP63 is related with the modulation of
these events is still under intense investigation.
In this regard, an important finding was that once L. mexicana
promastigotes are in contact with the extracellular matrix of sub-
cutaneous tissue, GP63 could degrade extracellular components
favoring its rapid migration on matrigel in vitro (McGwire et al.,
2003). In addition, this GP63-mediated protein degradation has
been also suggested as a key factor concurring to upregulate phos-
phatase activity in Leishmania-infected macrophages (see below
for further discussion), and might also mediate the resistance of
Leishmania to antimicrobial peptide.
Accordingly antimicrobial peptides are short cationic pep-
tide able to kill a wide range of microorganism including
Leishmania (Mangoni et al., 2005). One proposed mechanism
whereby Leishmania can escape the action of those peptides
is the GP63-mediated degradation of those latter, as L. major
GP63−/− mutants were found to be more susceptible to antimi-
crobial action (Kulkarni et al., 2006). Recently, host cell nucle-
osome histones involved in gene transcription where found to
have some anti-leishmania property. In fact, Wang et al. (2011)
showed that human histones H2A and H2B were able to kill
different Leishmania species and to decrease their infectivity.
And here again, L. amazonensis promastigotes deficient in GP63
were more susceptible to H2B, while L. major and L. mexicana
LPG-knockdown were more resistant (Wang et al., 2011), there-
fore, further supporting the importance of GP63 to protect
Leishmania against adverse conditions. Interestingly, histones are
present in the neutrophil extracellular traps (NETs), as well as in
many others antimicrobial components including myeloperoxi-
dase, elastase, and defensin (Papayannopoulos and Zychlinsky,
2009). NETs have been implicated in killing of L. amazonensis
(Guimaraes-Costa et al., 2009) and L. donovani LPG−/− (Gabriel
et al., 2010) promastigotes by neutrophils. However, L. donovani-
induced NET formation was shown not to be dependent on GP63
nor LPG expression (Gabriel et al., 2010). In this line of thought,
antimicrobial peptides and histones are important for antimi-
crobial defense of the host that can be avoided by Leishmania
expressing GP63.
RESISTANCE TO COMPLEMENT-MEDIATED LYSIS
Complement cascade can be activated by three pathways cul-
minating in the cleavage of C3–C3b. C3b binds to the target
serving as opsonin or to help activating other complement path-
way components. Microbes opsonized with C3b and C3bi are
recognized by complement receptor (CR) 1 (CD35) and CR3
(Cd11/CD18), respectively, consequently being phagocytized
and killed by phagocytes (Tosi, 2005). Therefore, complement-
mediated lysis of microbes is crucial in innate immunity.
Importantly, Leishmania sps. have evolved mechanisms to avoid
this complement-mediated killing fashion. Early studies demon-
strated an interaction between GP63 and C3, suggesting that
GP63 is the acceptor site for C3 deposition (Russell and Wilhelm,
1986; Russell, 1987). Later on, it has been demonstrated that
purified GP63 can cleave C3 to its breakdown products C3b
(117 kDa), C3bi (68 kDa), and to possibly generate others related
catabolites (C3c, C3d, C3e ∼29, and 43 kDa) (Chaudhuri and
Chang, 1988). The role of GP63 to cleave C3 was strengthened
by using Leishmania overexpressing GP63 or GP63 mutant
lacking activity. Leishmania overexpressing proteolytically active
GP63 was able to increase the conversion of C3b into C3bi
and to reduce the fixation of terminal complement compo-
nents to Leishmania, consequently increasing their resistance
to complement-mediated lysis comparatively to parasite over-
expressing inactive GP63 (Brittingham et al., 1995). The resis-
tance to complement-mediated lysis was confirmed with L. major
knockout (KO) to msp gene1–6 (expressing GP63 from msp gene
7 on late stationary phase) (Joshi et al., 1998) or 1–7 (Joshi
et al., 2002) as well as with antisense-down regulated GP63
in L. amazonensis (Thiakaki et al., 2006); all these Leishmania
showed increased sensitivity to complement killing. Additionally,
L. amazonensis expressing less GP63 and L. major GP63 KO were
found to develop a delayed cutaneous lesion formation in BALB/c
mice. However, GP63 (msp gene 1) added-back L. major mutant
only partially restored the resistance to complement and lesion
size, even with equivalent expression of surface GP63. The lat-
ter finding could be explained by a reduced proteolytic activity
of the restored GP63 or a defect in its released, which has been
tested in detail. Collectively, those studies have however, per-
mitted to firmly establish the protective role of GP63 against
complement-mediated lysis of Leishmania parasite.
PROMOTION OF AMASTIGOTE INTRA-MACROPHAGE SURVIVAL
Once the promastigote is internalized by phagocytosis, it trans-
forms into a non-flagellated amastigote form, able to survive,
and multiply within macrophage phagolysosome. Although the
expression (0.1% in amastigote vs. 1% in promastigote), the
posttranslational modifications, and the localization (membrane-
bound, soluble in cytosol, concentrated in the flagella pocket)
differs between both Leishmania life stages, GP63 has been iden-
tified in amastigotes of all Leishmania species studied so far
(Medina-Acosta et al., 1989; Frommel et al., 1990; Schneider et al.,
1992; Ilg et al., 1993; Hsiao et al., 2008). The role of GP63 in
amastigotes is still subject to discussion but several evidences
support its role in survival of parasite inside the macrophage.
Chaudhuri et al. (1989) showed that proteins entrapped in lipo-
somes are protected from phagolysosomal degradation when
coated with purified L. mexicana GP63. This protection is lost
when GP63 enzymatic activity is annihilated by heat denaturation
(Chaudhuri et al., 1989). Another study compared the survival
of virulent and attenuated variants of L. mexicana amazonen-
sis inside macrophages phagolysosomes. The low survival rate of
the attenuated variants was associated with 20–50-fold reduction
in the GP63 surface expression (Seay et al., 1996). In the same
idea, Chen et al. (2000) demonstrated that a low GP63 expression
induced by specific antisense RNAs in L. amazonensis promastig-
otes leads to a lower intracellular survival rate (Chen et al., 2000),
further confirming that GP63 could play a key role in protecting
the intracellular amastigotes in the host macrophages.
ALTERATION OF HOST MACROPHAGE SIGNALING BY GP63
The balance between phosphorylation and dephosphorylation
of Serine/Threonine/Tyrosine residues on structural and reg-
ulatory proteins by kinases and phosphatases respectively, is
critical to control intracellular mechanisms in eukaryotic cells.
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Consequently, Leishmania parasites are particularly effective to
hijack host macrophage signaling and antimicrobial functions by
exploiting the role of phosphatases as a negative regulator of these
pathways (Olivier et al., 2005). GP63 has been directly involved in
several of these parasite escaping mechanisms.
MARCKS PROTEIN AND GP63
One of the first molecules involved in signaling and been
affected by GP63 is the myristoylated alanine-rich C kinase sub-
strate (MARCKS) and the MARCKS related proteins (MRP),
which are protein kinase C (PKC) substrates in diverse cell
types, including macrophages (Aderem, 1992; Blackshear, 1993).
Expression of MARCKS and MRP is strongly up-regulated in
murine macrophages stimulated with bacterial lipopolysaccha-
ride and cytokines (Li and Aderem, 1992; Corradin et al., 1999a).
Interestingly, Corradin et al. (1999a) showed that L. major-
infected macrophages were showing a significant MRP depletion
(Corradin et al., 1999a), which latter can be inhibited in presence
of GP63 inhibitors, or when the GP63 potential cleavage site in
MRP is mutated, therefore confirming that GP63 is responsible
for the hydrolysis of MRP, a major PKC substrate in macrophages
(Corradin et al., 1999b). This finding is quite interesting as
PKC—a critical serine/threonine kinase involved in signal trans-
duction associated with cell proliferation, differentiation, and
apoptosis—is known to be greatly affected in Leishmania-infected
macrophages and to be responsible for the inhibition of antimi-
crobial agents such as radical oxygens (Olivier et al., 1992a,b) also
known to be caused by abnormal calcium-dependent signaling
occurring upon Leishmania infection (Eilam et al., 1985; Olivier
et al., 1992a). However, several studies highlighted a reduced PKC
activity in macrophages infected with L. donovani promastig-
otes (McNeely and Turco, 1987; Descoteaux et al., 1992; Olivier
et al., 1992b) and to be correlated with LPG inhibitory capac-
ity (Descoteaux et al., 1992). Interestingly, amastigotes—which
naturally lack LPG—were still able to inhibit PKC activity when
used to infect human monocytes (Olivier et al., 1992b), indicat-
ing the possibility that amastigote GP63-dependent alternative
mechanisms could be involved, but this still needs to be further
investigated, as well as the impact of amastigote cysteine proteases
of various Leishmania sps.
GP63-MEDIATED PTP ACTIVATION AND IMPACT ON JAK/STAT
SIGNALING PATHWAY
Of utmost interest, it is the discovery that the JAK1/2/STAT1α
pathway—a major player in IFN-γ signaling pathway—
responsible for the production of several toxic antimicrobial
agents such as nitric oxide, was greatly altered in Leishmania-
infected cells. And the fact that in the last decades or so,
Leishmania-induced activation of the protein tyrosine phos-
phatase (PTP) SHP-1 was found critical in that negative
regulation. Several groups reported that SHP-1 is involved in the
inhibition of JAK/STAT pathways IFN-γ stimulation (Nandan
and Reiner, 1995; Blanchette et al., 1999; Forget et al., 2006).
In-depth in vivo studies using SHP-1-deficient mice (viable
motheaten still have some SHP-1 activity) confirmed that
SHP-1 is important for L. major survival and progression within
footpad of its mammalian host by dampening NO dependent
and independent microbicidal mechanisms (Forget et al., 2001,
2005b). However, others (Spath et al., 2008) claim that SHP-1
was not involved, having solely observed an initial significant
reduction of lesion on the rump followed by a normal progres-
sion of the lesion development few weeks later. This discrepancy
could be accounted to several factors such as site of infection,
mice microbiota (that could have influence SHP-1 expression),
germ-free animal facility, as well as, and importantly, age at
which mice where used. Nevertheless, since then other PTPs have
been found to be induced upon Leishmania infections, and to be
involved in the progression of leishmaniasis.
In regards to the role of GP63 in the activation of this negative
regulation of host signaling, it is only recently that Gomez et al.
(2009) highlighted that the parasite metalloprotease was a criti-
cal player in PTP activation. Using L. major wild-type, GP63−/−
and GP63 rescued strains, it has been demonstrated that GP63
is responsible for the activation upon cleavage at the C′ termi-
nal portion of the PTPs- of SHP-1, PTP1B and TCPTP. It was
showed that GP63 directly interacts with those cytoplasmic PTPs
upon its entrance via lipid raft microdomains (Gomez et al.,
2009). Whereas the used of TCPTP−/− mice is not possible—
as they are viable only for short time after birth—for infectious
challenge, PTP1B−/− mice infected with L. major showed a
delay in the onset and progression of footpad inflammation and
reduced parasite burden in the early stages of the disease com-
pared to wild-type mice. This latter observation being another
demonstration that PTPs have to some extend a role to play in
the strategy used by Leishmania parasite to subvert host innate
immune response favoring its survival and progression. What
this study also revealed is that several PTPs being modulated by
Leishmania could be necessary to have a full infectious impact
on the host. In fact, it will be interesting in a near future to test
whether a triple knock-out of those main PTPs identified to be
modulated by Leishmania infection, could confer a robust protec-
tion for the host. This is quite realistic, as those three PTPs (e.g.,
SHP-1, PTP1B, SHP-1) have been demonstrated to be critical in
the control of JAK/STAT pathways in regards to IFN-γ signaling
(Simoncic et al., 2002; ten Hoeve et al., 2002).
As another consequence of the GP63-mediated activation of
PTPs, it has been demonstrated that Leishmania-infected cells
where refractory to LPS stimulation due to the inactivation of
toll like receptor (TLR) signaling. More precisely, Abu-Dayyeh
et al. (2008) found that upon Leishmania infection, SHP-1 rapidly
binds to one of the central kinases of TLR pathway, the IRAK-1,
completely inactivating its kinase activity and any further LPS-
mediated activation, as well as macrophage functions. Explaining
in part, the negative regulatory mechanisms that concur to tame-
down several LPS-induced macrophage functions (TNF-α, NO,
IL-12) upon Leishmania infection reported by several groups
(review in Abu-Dayyeh et al., 2008).
PTPs AND MAP KINASE (MAPK) FAMILY
The three major MAPK (Mitogen Activated Protein Kinases)
studied are ERK1/2, p38 and SAPK/JNK (Stress Activated
Protein Kinase/C-Jun Kinase). Their activation requires dual
phosphorylation of serine/threonine and tyrosine residues, and
therefore their deactivation occurs through the action of PTPs,
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serine/threonine phosphatases (STPs), or dual specificity phos-
phatases (DSPs). Inhibition ofMAPK following Leishmania infec-
tion and involving PTPs has been reported by different groups
using L. amazonensis or L. donovani (Martiny et al., 1999; Nandan
et al., 1999; Forget et al., 2006). In all studies, it was suggested
that PTPs are responsible for ERK1/2 dephosphorylation. Later
on, SHP-1 has been shown to be involved in ERK1/2 and the
SAPK/JNK dephosphorylation (Forget et al., 2006; Blanchette
et al., 2009). Whereas GP63 has not been proved to impact
directly on MAPK inactivation, GP63-mediated SHP-1 activation
is more than likely to be involved. However, we have indica-
tion that JNK kinase is cleaved by GP63 (Contreras and Olivier,
unpublished data) and it could, therefore, have an impact on that
branch of MAPK signaling. In fact as we recently revealed (see
below in details), the downstream signaling target of JNK, namely
c-Jun, is also degraded by GP63 (Contreras et al., 2010).
Concerning the implications of the other phosphatases (STPs
and DSPs) mentioned earlier, they have been found to neg-
atively regulate MAPK signaling during Leishmania infection
(Al-Mutairi et al., 2010; Kar et al., 2010; Srivastava et al., 2011).
For instance STP PP2 and DSPMKP1 were found to regulate p38
activity, whereas MKP3 preferentially controls ERK1/2 (Kar et al.,
2010). However, a role of GP63 in their activation process has not
been studied.
GP63 AND mTOR-DEPENDENT SIGNALING
In regards to signaling molecules targeted by Leishmania GP63,
a recent study by Jaramillo et al. (2011) revealed that L. major
can also promote its survival by down regulating host macrophage
protein synthesis under CAP-dependent translational events. This
down regulation was found to be cause by the GP63-mediated
alteration of mTORC1-dependent signaling which is pivotal for
the regulation of this translational system. Importantly, GP63
deficient L. major promastigotes were not perturbing mTOR
integrity and therefore not affecting translation initiation. This
recent study highlighted a brand new subversion mechanism of
Leishmania toward host macrophage functions, as to show how
this parasite can also modify cytokine profiles favoring or at least
taming down the development of an efficient anti-Leishmania
adaptive immune response (Jaramillo et al., 2011).
INFLUENCE OF GP63 ON MACROPHAGE TRANSCRIPTION FACTORS
There is several transcription factors involved in the regulation
of macrophage-specific gene expression such as NF-κB, STAT1,
and AP-1. Whereas NF-κB family intervenes in gene expression
involved in a wide range of macrophage functions, the STAT fam-
ilymembers are known for their central role in cytokine-mediated
signaling, such as in IFN-γ-induced iNOS expression. Of interest,
several studies showed that Leishmania infection alters STAT1α
signaling (Ray et al., 2000; Rosas et al., 2003; Forget et al., 2005a).
However, this alteration does not solely result from the PTP-
mediated inhibition of JAK2 and MAPK kinases up-stream of the
biochemical cascade, but also involved the rapid degradation of
STAT1α by nuclear proteasome machinery under PKC-α regula-
tion (Forget et al., 2005a). Unpublished observations from our
laboratory suggest that GP63 could be involved, however at that
time we were not suspecting that LeishmaniaGP63 was capable to
reach macrophage nuclear compartment.
In regard to the more pleiotropic transcription factor NF-κB,
Gregory et al. (2008) reported that various Leishmania sps. infect-
ing macrophage were effective to induce the specific cleavage
of the NF-κB p65RelA subunit in the cytoplasm, releasing a
p35RelA that migrates to the nucleus where it binds DNA as a
heterodimer with NF-κB p50. This cleavage was shown to be
GP63-dependent (Gregory et al., 2008) and to be critical for
the induction of selected chemokines by Leishmania-infected
macrophages. Importantly, modulation of other NF-κB family
members upon infection of human phagocytes by Leishmania
have been reported and also found to influence host cell cytokine
production (Guizani-Tabbane et al., 2004). In addition to GP63,
the cysteine peptidases of L. mexicana amastigotes were found
to act more drastically on NF-κB by almost completely degrad-
ing this latter and therefore concurring to strongly shutdown
LPS-induced IL-12 production by macrophages (Cameron et al.,
2004).
In addition to the transcription factors NF-κB and STAT1α,
it has been reported by several laboratories that AP-1, also crit-
ical in IFN-γ-induced NO production, was strongly affected by
Leishmania infection (review in Olivier et al., 2005). Per se, AP-1
is formed by homodimers of Jun family members (c-Jun, JunB,
and Jun D), or heterodimers of Jun and Fos family members
(c-Fos, Fos B, Fra 1, and Fra 2) (Karin et al., 1997). As mentioned
above, previous studies have reported that Leishmania infection
concurs to inactivate the AP-1 transcription factor. For instance,
it has been proposed that ceramide augmentation—measured
in cells infected with L. donovani promastigotes—is responsible
for macrophage PKC and ERK1/2 signaling alteration leading to
AP-1 inactivation (Ghosh et al., 2001, 2002). In the same vein,
other studies have also shown that Leishmania alters signal trans-
duction upstream of c-Fos and c-Jun by inhibiting ERK, JNK,
and p38 MAP Kinases, resulting in a reduction of AP-1 nuclear
translocation (Nandan et al., 1999; Privé and Descoteaux, 2000).
However, by lookingmore closely at AP-1 nuclear integrity during
Leishmania infection, we have investigated how GP63 contributes
to AP-1 inactivation and the degradation of its various subunits
forming this transcription factors. Of utmost interest, we found
that GP63 after rapidly reaching macrophage cytoplasm via lipid
raft microdomains—as during the process leading to PTP acti-
vation earlier—and independently of parasite internalization, it
is able to reach the nuclear compartment where it degrades and
cleaves c-Jun and other AP-1 subunits and therefore drastically
affect the integrity of the transcription factor AP-1 during the
early moment of Leishmania infection (Contreras et al., 2010).
As AP-1 is a critical transcription factor involved in the regula-
tion of innate inflammatory response, we sincerely believe that its
rapid inactivation, concurrently with the modification of NF-κB
behavior, must favor the parasite to survive by sufficiently taming
down the initial macrophage inflammatory and anti-microbial
responses—and potentially of other phagocytic cells—that are
not fully inhibited, as some chemokines are known to be secreted
during the early moments of infection leading to the recruitment
of phagocytic cells to the site of infection. Thus at the view of these
evidences, it is clear that the Leishmania metalloprotease GP63 is
Frontiers in Cellular and Infection Microbiology www.frontiersin.org May 2012 | Volume 2 | Article 72 | 5
Isnard et al. Leishmania GP63 and macrophage signaling
strongly influencing the transcription factors of the host cells as
another way whereby it can influence the macrophage functions
to survive and progress.
INFLUENCE OF Leishmania GP63 ON OTHER IMMUNE CELLS
Although macrophages are the primary host cells harboring
amastigotes following initial infection, other cells of the innate
immune system are known to be involved in the establishment
of the infection by the parasite Leishmania, and their functions
could be also influenced by GP63. For instance, Lieke et al. (2008)
showed that proliferation, receptor expression and IFN-γ released
by natural killer (NK) cells are affected by L. major GP63, which
could have an important impact by inhibiting the Th1 immune
response, crucial to control the parasite infection (Lieke et al.,
2008). Importantly, NK cells have been shown to be affected
by secreted GP63, as this cell type is not phagocytic and never
been reported to be infected per se. On the other hand, cer-
tain cell types known to be non-phagocytic can become infected
by Leishmania. Accordingly, fibroblasts, which are abundant in
the immediate environment where promastigotes are usually
inoculated—as well as part of cells forming lymph nodes—have
been reported in mouse infection to internalize parasites (Bogdan
et al., 2000). Their limited capacity to eliminate parasites due to a
low NO production imply that these cells could act as a reser-
voir for long term infection. In support of this, we found that
Leishmania-infected fibroblasts are greatly affected at the signal-
ing level (Halle et al., 2009). In fact we showed that in those cells,
L. major parasite, via its GP63, modifies several host signaling
proteins involved in rearrangement of the actin cytoskeleton and
in MAPK-signaling pathway, such as the phosphorylated adap-
tor protein p130Cas, the PTP-PEST, cortactin, the T Cell-protein
tyrosine phosphatase TC-PTP, caspase-3, and p38 via the p38 reg-
ulator TAB1. These results confirm the key role of GP63 in a
number of host cell molecular events, other than in macrophage,
which could contribute to Leishmania survival and progression
within its mammalian host.
Finally, there has been growing evidence for the potential role
of neutrophils during the early stages of Leishmania infection. This
cell type is known to be rapidly recruited to infection sites—aswell
as monocytes and macrophages—and to favor the presentation
of internalized parasites to macrophages that are the final cellular
host of Leishmania. Interestingly, it has been shown in a previous
study, that neutrophils incubation with L. major GP63 inhibits
both their chemotaxis and oxidative burst in a dose–dependent
manner; which inhibitory effect was completely abolished by
heat inactivation (Sorensen et al., 1994). In addition, it is well
known that phagocytosis is one of the best characterized killing
mechanisms in neutrophils. Importantly, it has been reported
in the last 10 years that neutrophils are very effective to kill
microbes using NETs, which is composed of released chromatin
and specific granule proteins in response to various stimuli, and
found to kill various microorganisms (Brinkmann et al., 2004).
Recently, Gabriel et al. (2010) demonstrated that L. donovani
promastigotes induce the rapid release of NETs from human
neutrophils concurring to the capture of Leishmania by these
structures. Interestingly, this was not causing the death of the
parasite that could escape thereafter. Using Leishmania deficient
for GP63, they found that the parasite metalloprotease, was not
involved neither in the induction of NETs by Leishmania, nor in
the parasite resistance to their microbicidal activity (Gabriel et al.,
2010). This finding is refreshing as it reveals that GP63 does not
only have a systemic impact on cellular and functional target of
the host cell, but that can be selective in its action.
CONCLUDING REMARK
At the view of the findings reported above, it is quite clear that
Leishmania GP63 is a very powerful protease that can rapidly act
on a wide range of host cell substrates involved in cell signaling
pathways and their regulation. Impact of GP63 on antimicrobial
and inflammatory functions of macrophage has been extensively
documented, further reinforcing its pivotal role as an impor-
tant virulence factors contributing to its survival during the
initial stage of the infection. The full profile of host proteins
affected by GP63 is still unraveled and it will be important in
a near future to identify them as to potentially develop new
therapies to control Leishmania infection. Another important
avenue to follow is to better understand the mechanisms whereby
Leishmania GP63 enters the cytoplasmic and the nuclear com-
partment of infected cells. One of the mechanisms that have been
proposed comes from our demonstration (Gomez et al., 2009;
Gomez and Olivier, 2010) that GP63 was found to co-localize
with macrophage lipid rafts during Leishmania infection, and
that this GP63 entrance and co-localization was abrogated by
the depletion of lipid raft cholesterol using β-cyclodextrin. This
blockage of GP63 entrance was also reflected by absence of cleav-
age and of PTPs activation (SHP-1 and PTP1B). Interestingly,
that perturbation of lipid raft integrity did not impair TCPTP
cleavage, thus indicating an alternative mechanism of GP63
internalization (Gomez et al., 2009). In this regard, we sus-
pect that GPI-anchored GP63 is favored to enter via lipid raft
microdomains, whereas GP63 that is not GPI-anchored (as three
different forms of GP63 can be found in the parasite) enter
through a yet unidentified mechanism to reach nuclear compart-
ment to cleave and activate TCPTP. Recently, Silverman et al.
(2010) proposed that excreted vesicules from L. donovani, the
exosomes, could fuse with macrophage once in the phagolysoso-
mal compartment to release its content into the cytoplasm of the
infected cells (Silverman et al., 2010). In support of this, Hassani
et al. (2011) showed that L. mexicana exoproteomes—also con-
taining exosome having budded from the parasite surface upon
temperature shift (see Figure 2)—contain GPI-anchored GP63
FIGURE 2 | Temperature shift (25–37◦C) induces formation of
exosomes at the surface of Leishmania mexicana promastigotes.
(Arrows point at emerging exosomes). Hassani and Olivier
Frontiers in Cellular and Infection Microbiology www.frontiersin.org May 2012 | Volume 2 | Article 72 | 6
(unpublished).
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(Hassani et al., 2011). Therefore, the rapid movement of GP63
within macrophage cytoplasm could come from exosome fusion
with the macrophage plasma membrane and represent another
route for GP63 entry within the host macrophage environment.
Collectively, the Leishmania metalloprotease GP63 is still just
revealing its importance as a critical virulence factor, and future
research will be warranted to be pursued in order to fully appre-
ciate its impact on host cell functions, as a better knowledge of its
mode of action could lead to the development of new therapeutic
and even new prophylactic (Olivier and Hassani, 2010) to reduce
its infectivity and capacity to invade mammalian macrophages.
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